NEW MJ NEWS

AbbVie to Host Second-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2021-earnings-conference-call-301326236.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc (TBPMF) Signs License Agreement with Thorne for a Prebiotic Dietary Supplement

Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement…

Neptune Wellness Solutions Inc. (NEPT) to Report Fiscal 2021 First Quarter Financial Results on August 11, 2020

Neptune to Report Fiscal 2021 First Quarter Financial Results on August 11,…

Village Farms International, Inc. (VFF) Announces Participation at the Benzinga Cannabis Capital Conference in Chicago

Village Farms International Announces Participation at the Benzinga Cannabis Capital Conference in…

Tetra Bio-Pharma Inc. (TBPMF) Provides Corporate Update Ahead of Its Annual General Meeting

Tetra Bio-Pharma Inc. Provides Corporate Update Ahead of Its Annual General Meeting…